Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

(Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...

Significantly lower AMD risk compared with other agents in cohort study ...

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism ...

A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...

About Dr. James Leong: Dr. James Leong is an Oxford fellowship-trained consultant ophthalmologist specializing in medical retina, uveitis, and refractive cataract surgery. He is the founder of The Eye ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.

Since Roche launched its long-acting eye disease medicine Vabysmo in 2022, Bayer and Regeneron have seen the impact on sales of their rival treatment Eylea, with the U.S. biotech taking a bigger hit.

But when the retina is damaged, vision can slowly become blurred, distorted or permanently lost, often before a person even ...

Many common conditions linked to aging develop without symptoms for years. Learn which five pose the biggest risks and the ...

Detailed price information for Kalaris Therapeutics Inc (KLRS-Q) from The Globe and Mail including charting and trades.

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...